Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

U.S. to share 4 million doses of AstraZeneca COVID-19 vaccine with Mexico, Canada

Published 2021-03-18, 12:00 p/m
© Reuters. FILE PHOTO: AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo
PFE
-
JNJ
-
AZN
-

By Jeff Mason

WASHINGTON (Reuters) - The United States plans to send roughly 4 million doses of AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine that it is not using to Mexico and Canada in loan deals with the two countries, bowing to pressure to share vaccine with its allies.

Mexico will receive 2.5 million doses of the vaccine and Canada is to receive 1.5 million doses, White House spokeswoman Jen Psaki said.

"It is not fully finalized yet but it is our aim," she told a daily briefing.

The Biden administration has come under pressure from countries around the world to share vaccines, particularly its stock of AstraZeneca, which is authorized for use elsewhere but not yet in the United States.

AstraZeneca has millions of doses made in a U.S. facility, and has said that it would have 30 million shots ready at the beginning of April. The company's shares rose slightly after Reuters first reported the news.

The deal to share the vaccine does not affect President Joe Biden's plans to have vaccine available for all adults in the United States by the end of May, a senior administration official said, and it does not reduce the supply of available vaccine in the United States.

Two officials said the vaccine would be delivered in "short order" once the deal was completed, but they declined to give a more specific timetable.

The so-called "releasable" vaccines should be ready for use once they arrive in Mexico and Canada. Under the deal, the United States will share doses with the two countries now with the understanding that they will pay the United States back with doses in return. The official said that would take place later this year.

Psaki said the United States had access to 7 million releasable doses of the AstraZeneca vaccine but had no plans to share the vaccine with other countries at this time.

"We ... have a number of requests from a range of countries around the world and certainly we'll continue those conversations," she said.

Asked why Mexico and Canada were chosen, the administration official said: "They are our neighbors, they are our partners."

'MORE WORK TO DO'

Mexican President Andres Manuel Lopez Obrador had requested the vaccine previously. The official said the countries were in touch about the vaccine loan. "We've been working through the diplomatic channels," he said.

"We’re having positive conversations with the U.S. Those conversations are fairly advanced but there's more work to do," a senior Canadian government source said.

Reports of blood disorders have prompted more than a dozen nations to suspend use of AstraZeneca's vaccine but on Thursday the European Union's drug watchdog said that after an investigation it is still convinced the benefits of that vaccine outweigh the risks.

A spokeswoman for AstraZeneca declined to comment on the deal but noted that its doses in the United States were owned by the U.S. government.

Biden has said if the United States has a surplus of vaccine, it will share it with the rest of the world. The White House has focused on vaccinating people in the United States, which has seen more than 530,000 people die from virus.

The country is getting prepared to roll out the AstraZeneca vaccine domestically if it gets authorization from the U.S. Food and Drug Administration, the White House said.

The United States has pledged $4 billion to the global COVAX vaccine program that aims to deliver coronavirus vaccines to poor countries.

The United States does not need the AstraZeneca shots to meet its target of having enough doses for all U.S. adults by the end of May.

The three authorized vaccine makers – Pfizer (NYSE:PFE) Inc/BioNTech SE, Moderna Inc, and Johnson & Johnson (NYSE:JNJ) – have promised to deliver nearly 500 million doses to the United States by then.

© Reuters. Vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine is pictured in Berlin

The U.S. decision to loan the AstraZeneca doses comes as Mexico has in recent weeks leaned increasingly on China and Russia to secure vaccines to carry out its inoculation plans.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.